Ocugen to present modifier gene therapy platform at Oppenheimer biotech summit
OCGN•Upcoming conference presentations
Ocugen will present its modifier gene therapy platform at the Oppenheimer Biotech in the Berkshires Summit on Aug. 4, 2026, in Lenox, Massachusetts.
The company will also take part in the Canaccord Annual Growth Conference on Aug. 11, 2026, in Boston.
